Achilles Therapeutics Pl-adr Share Price Today
(NASDAQ: ACHL)

Name: Achilles Therapeutics Pl-adr Share Price Today (NASDAQ: ACHL) - Achilles Therapeutics Pl-adr Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Achilles Therapeutics Pl-adr share price is $1.39 & ₹120.89 as on 6 Mar 2025, 2.30 'hrs' IST

$1.39

▲

0.02

(1.46%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Achilles Therapeutics Pl-adr share price in Dollar and Rupees. Guide to invest in Achilles Therapeutics Pl-adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Achilles Therapeutics Pl-adr, along with analyst recommendations, forecasts, and comprehensive financials.

Achilles Therapeutics Pl-adr share price movements

Today's Low: $1.37
Today's High: $1.39
$1.39
1.44%
Downside
Day's Volatility :1.44%
Upside
0.0%
52 Weeks Low: $0.63
52 Weeks High: $1.41
$1.39
54.68%
Downside
52 Weeks Volatility :55.32%
Upside
1.42%

Achilles Therapeutics Pl-adr (ACHL) Returns

Period	Achilles Therapeutics Pl-adr	Sector (Health Care)	Index (Russel 2000)
3 Months	33.65%	3.7%	0.0%
6 Months	95.55%	-2.8%	0.0%
1 Year	12.1%	2.5%	0.0%
3 Years	-51.06%	12.9%	-11.6%

Achilles Therapeutics Pl-adr (ACHL) Key Statistics

in dollars & INR

Previous Close	$1.37
Open	$1.38
Today's High	$1.39
Today's Low	$1.37
Market Capitalization	$58.5M
Today's Volume	$3.1M
52 Week High	$1.41
52 Week Low	$0.63
Revenue TTM	$0.0
EBITDA	$-67.2M
Earnings Per Share (EPS)	$-1.65
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-52.12%

How to invest in Achilles Therapeutics Pl-adr Stock (ACHL) from India?

It is very easy for Indian residents to invest directly in Achilles Therapeutics Pl-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Achilles Therapeutics Pl-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Achilles Therapeutics Pl-adr or ACHL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Achilles Therapeutics Pl-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Achilles Therapeutics Pl-adr shares which would translate to 0.626 fractional shares of Achilles Therapeutics Pl-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Achilles Therapeutics Pl-adr, in just a few clicks!

Returns in Achilles Therapeutics Pl-adr (ACHL) for Indian investors in Rupees

The Achilles Therapeutics Pl-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Achilles Therapeutics Pl-adr investment value today

Current value as on today

₹1,17,046

Returns

₹17,046

(+17.05%)

Returns from Achilles Therapeutics Pl-adr Stock

₹12,097 (+12.1%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Achilles Therapeutics Pl-adr (ACHL)

-33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Achilles Therapeutics Pl-adr Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Achilles Therapeutics Pl-adr

Syncona Portfolio Ltd.
26.98%
BML Capital Management LLC
9.98%
FCPM III SERVICES BV
5.82%
Redmile Group, LLC
3.91%
Vestal Point Capital LP
3.65%
Ikarian Capital, LLC
3.51%

Analyst Recommendation on Achilles Therapeutics Pl-adr

Buy

70%Buy

20%Hold

10%Sell

Based on 10 Wall street analysts offering stock ratings for Achilles Therapeutics Pl-adr(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Achilles Therapeutics Pl-adr Stock (ACHL)

What analysts predicted

Downside of 64.03%

Target:

$0.50

Current:

$1.39

Insights on Achilles Therapeutics Pl-adr Stock (Ticker Symbol: ACHL)

Price Movement
In the last 3 months, ACHL stock has moved up by 33.7%
ACHL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 54.4%
ACHL vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 102.0%

Achilles Therapeutics Pl-adr Technicals Summary

Sell

Neutral

Buy

Achilles Therapeutics Pl-adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Achilles Therapeutics Pl-adr (ACHL) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Achilles Therapeutics Pl-adr	2.21%	95.55%	12.1%	-51.06%	-80.45%
Regeneron Pharmaceuticals, Inc.	-1.42%	-40.28%	-29.31%	11.08%	44.83%
Beone Medicines Ltd	17.63%	36.87%	64.37%	45.89%	71.3%
Vertex Pharmaceuticals Incorporated	1.94%	4.92%	19.37%	108.73%	123.83%
Alnylam Pharmaceuticals, Inc.	-8.03%	-0.89%	66.53%	52.9%	126.66%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Achilles Therapeutics Pl-adr	0.17	NA	NA	-0.18	-0.52	-0.3	NA	2.51
Regeneron Pharmaceuticals, Inc.	17.86	17.86	1.01	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Achilles Therapeutics Pl-adr	Buy	$58.5M	-80.45%	0.17	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$73.8B	44.83%	17.86	31.07%
Beone Medicines Ltd	NA	$29.1B	71.3%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.9B	123.83%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	126.66%	NA	-12.37%

About Achilles Therapeutics Pl-adr

Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

Organization	Achilles Therapeutics Pl-adr
Employees	204
CEO	Dr. Iraj Ali Ph.D.
Industry	Healthcare

Management People of Achilles Therapeutics Pl-adr

Name	Title
Dr. Iraj Ali Ph.D.	CEO & Director
Dr. Sergio A. Quezada Ph.D.	Founder
Mr. Robert Coutts	Chief Financial Officer
Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D.	Founder & Member of Scientific Advisory Board
Dr. Charles Swanton FMEDSCI, M.D., Ph.D.	Founder & Member of Scientific Advisory Board
Mr. Lee M. Stern	Vice President of Investor Relations & External Communications
Mr. Daniel Carey Cazel Hood	General Counsel & Company Secretary
Julia Wilson	Head of Communications
Mr. Tariq Ahmed	Executive Vice President of People

Important FAQs about investing in ACHL Stock from India :

What is Achilles Therapeutics Pl-adr share price today?

Achilles Therapeutics Pl-adr share price today stands at $1.39, Open: $1.38 ; Previous Close: $1.37 ; High: $1.39 ; Low: $1.37 ; 52 Week High: $1.41 ; 52 Week Low: $0.63.

The stock opens at $1.38, after a previous close of $1.37. The stock reached a daily high of $1.39 and a low of $1.37, with a 52-week high of $1.41 and a 52-week low of $0.63.

Can Indians buy Achilles Therapeutics Pl-adr shares?

Yes, Indians can invest in the Achilles Therapeutics Pl-adr (ACHL) from India.

With INDmoney, you can buy Achilles Therapeutics Pl-adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Achilles Therapeutics Pl-adr at zero transaction cost.

How can I buy Achilles Therapeutics Pl-adr shares from India?

It is very easy to buy Achilles Therapeutics Pl-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Achilles Therapeutics Pl-adr (ACHL) be purchased?

Yes, you can buy fractional shares of Achilles Therapeutics Pl-adr with INDmoney app.

What are the documents required to start investing in Achilles Therapeutics Pl-adr stocks?

To start investing in Achilles Therapeutics Pl-adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.